Blog - Latest News
You are here: Home1 / Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia2 / Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical...
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
- Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK
- Treatment intensification with radium-223 plus enzalutamide in patients with metastatic castration-resistant prostate cancer
- Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP)
- 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy
Leave a Reply
Want to join the discussion?Feel free to contribute!